Results 11 to 20 of about 11,531,725 (348)
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
Pharmacological Reviews, 2022 Our previous International Union of Basic and Clinical Pharmacology report on the nomenclature and classification of adenosine receptors (2011) contained a number of emerging developments with respect to this G protein-coupled receptor subfamily ...
A. IJzerman +4 more
semanticscholar +1 more source
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Clinical Pharmacokinetics, 2021 The absorption, distribution and elimination of oral semaglutide, the first oral glucagon-like peptide-1 receptor agonist for treating type 2 diabetes, was investigated using a population pharmacokinetic model based on data from clinical pharmacology ...
R. V. Overgaard +4 more
semanticscholar +1 more source
Drug Metabolism And Disposition, 2022 RNA-based oligonucleotide therapeutics are revolutionizing drug development for disease treatment. This class of therapeutics differs from small molecules and protein therapeutics in various ways, including both its mechanism of action and clinical ...
Xing Jing +3 more
semanticscholar +1 more source
Clinical Pharmacology of Antibody-Drug Conjugates
Antibodies, 2021 Antibody-drug conjugates (ADCs) are biopharmaceutical products where a monoclonal antibody is linked to a biologically active drug (a small molecule) forming a conjugate.
I. Mahmood
semanticscholar +1 more source
Filgotinib: A Clinical Pharmacology Review
Clinical Pharmacokinetics, 2022 Filgotinib (GS-6034, formerly GLPG0634; Jyseleca®) is an oral, preferential Janus kinase (JAK)-1 inhibitor. Preferential inhibition of JAK1 modulates a subset of proinflammatory cytokines within the JAK–signal transducer and activator of transcription ...
F. Namour +3 more
semanticscholar +1 more source
Sex and Gender Differences in Clinical Pharmacology: Implications for Transgender Medicine
Clinical pharmacology and therapy, 2021 The transgender adult population is growing globally, but clinical pharmacology has lagged behind other areas of transgender medicine. Medical care for transgender adults may include long‐term testosterone or estrogen treatment to align secondary sex ...
Lauren R. Cirrincione, Kai J. Huang
semanticscholar +1 more source
Pharmaceuticals, 2023 The prescriptive appropriateness of Proton Pump Inhibitors (PPIs) in polypharmacy is controversial. PPIs are often overprescribed and the risk of prescribing errors and adverse drug reactions increases for each additional drug added to therapy.
Giammarco Baiardi +7 more
doaj +1 more source
Basic & Clinical Pharmacology 14th Edition
Central Asian Journal of Medical Sciences, 2020 No abstract in ...
Narantungalag Dorjsuren
doaj +1 more source
Children, 2023 This was a single center, retrospective cohort study designed to evaluate the association between the administration of inotropes to hypotensive very low gestational age infants (VLGAI) and prenatal and neonatal risk factors.
Theodora Stathopoulou +5 more
doaj +1 more source
Pharmacy, 2021 Judicious use of medicines that considers evidence-based practice, together with cost-effectiveness, is a priority for all health care organisations. We describe an initiative to lead a Medication Utilisation Program, incorporating medication quality ...
Karen Whitfield +3 more
doaj +1 more source